TATA HEALTH(01255): Zhang Mingqi has been transferred from a non-executive director to an executive director.
TATA Health (01255) announced that Mr. Zhang Mingqi has been transferred from a non-executive director to an executive director, and has been appointed as...
TATA HEALTH (01255) announces that Mr. Zhang Mingqi, previously a non-executive director, has been appointed as an executive director and CEO of the company, effective from October 21, 2025.
Mr. Xu Jianda will be appointed as the Chief Financial Officer of the company, effective from October 21, 2025.
Related Articles

Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


